AACR
| 6 min read
Larkspur Biosciences scientists develop drugs that make colorectal cancer tumors vulnerable to killing by the immune system and cell death pathways.
| 5 min read
IO Biotech’s two-pronged cancer vaccine targets tumors and the suppressive immune cells around them, demonstrating promising results in metastatic melanoma.
| 3 min read
Backed by patient data and an AI platform, the BPGbio team presented promising results for a mitochondrial-targeted therapy in glioblastoma at AACR 2025.
| 5 min read
Among the thrill of new results presented at the AACR 2025 conference, the specter of funding cuts to cancer research hung over the meeting.
Page 1 of 1 - 4 Total Items
